BREAST CANCER

Medicare to pay for Avastin regardless of FDA

Worker at Roche
The Centers of Medicare and Medicaid said that Medicare will continue to pay for ?Avastin? when it is prescribed to treat metastatic breast cancer, regardless of what the FDA would decide.
More news
IBTimes Logo

Bored with same old e-mail's look? Try this...

MeebleMail.com, enables consumers to turn drab everyday email into stylish personalized stationery. It features a library of over 500 designs that appeal to a wide variety of tastes – from contemporary and sophisticated to whimsical.
John Edwards and his daughter Cate Edwards depart from the U.S. District Court in Winston-Salem North Carolina

The Rise, and Fall, of John Edwards

At one time, he seemingly had it all: A political career to boast of, a name everyone - or at least most Democrats - respected, a wife that loved him for 32 long years, and four children to show for it. But, oh, how easy it is to fall; one faulty move and the king is in check. It is this position John Edwards now finds himself.

Coffee: Reducing The Risk Of Breast Cancer

Consumption of coffee will actually decrease the risk of developing a certain kind of breast cancer according to what Swedish researchers found. What they did is that they compared the consumption of coffee in postmenopausal women diagnosed with cancer and women of the same age with no cancer.
IBTimes Logo

Immunogen Shares Hit New High on Breast Cancer Study Results

Shares of Immunogen Inc. (NASDAQ: IMGN) touched a new 52-week high and a 9-year high of $12.03 on Thursday. Roche Holding AG said an experimental drug T-DM1 was effective in a mid-stage study of breast cancer patients whose disease has spread.
Coming soon, a smart phone App to detect cancer in 60 minutes

Coming soon, a smart phone App to detect cancer in 60 minutes

A mobile phone can spot cancer and soon there may be an application to detect it and could allow physicians to find out within 60 minutes whether a suspicious lump in a patient is cancerous or benign, Science Translational Medicine journal said in a report on Friday.
IBTimes Logo

Roche sees U.S. and European reforms weighing in 2011

Swiss drugmaker Roche struck a cautious note on 2011, as the sector grapples with U.S. healthcare reforms and a push in Europe for lower drug prices, after growth of its top-seller Avastin slowed sharply in 2010.
IBTimes Logo

Blocking ‘rogue’ gene could stop cancer spread

Scientists in the United Kingdom have identified a “rogue” gene that attacks and breaks down a naturally-occurring protein in the body which normally prevents cancer cells spreading. By blocking the WWP2 gene, which is an enzymic bonding agent found inside cancer cells, levels of the natural inhibitor are boosted and the cancer cells remain dormant.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.